Literature DB >> 7695197

C-type natriuretic peptide inhibits intimal thickening after vascular injury.

M Furuya1, T Miyazaki, N Honbou, K Kawashima, T Ohno, S Tanaka, K Kangawa, H Matsuo.   

Abstract

Recently we have found that C-type natriuretic peptide (CNP) inhibits proliferation of cultured rat vascular smooth muscle cells through an elevation of cGMP. We have now tested whether administration of CNP inhibits the development of intimal lesions induced by air-drying injury in rat common carotid arteries in vivo. CNP treatment (1 microgram/kg per min, iv infusion) for either 14 or 5 days resulted in 70% or 60% reduction, respectively, of intimal cross-section area 14 days after injury as compared with control rats. We also found that CNP potently stimulated cGMP production in injured carotid arteries with intimal thickening, but not in intact ones. These results indicate that GC-B, CNP specific receptor/guanylyl cyclase, is expressed at the sites of vascular injury, and that CNP might be efficacious in the prevention of restenosis caused by intimal thickening following coronary angioplasty.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7695197     DOI: 10.1111/j.1749-6632.1994.tb17352.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

Review 1.  Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides.

Authors:  Camilla Calvieri; Speranza Rubattu; Massimo Volpe
Journal:  J Mol Med (Berl)       Date:  2011-08-09       Impact factor: 4.599

2.  Endogenous vascular synthesis of B-type and C-type natriuretic peptides in the rainbow trout.

Authors:  Keven R Johnson; Todd M Hoagland; Kenneth R Olson
Journal:  J Exp Biol       Date:  2011-08-15       Impact factor: 3.312

3.  Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging.

Authors:  S Jeson Sangaralingham; Denise M Heublein; Joseph P Grande; Alessandro Cataliotti; Andrew D Rule; Paul M McKie; Fernando L Martin; John C Burnett
Journal:  Am J Physiol Renal Physiol       Date:  2011-08-24

4.  Synthesis of a series of benzothiazole amide derivatives and their biological evaluation as potent hemostatic agents.

Authors:  Wenqian Nong; Anran Zhao; Jinrui Wei; Hui Cheng; Xuan Luo; Cuiwu Lin
Journal:  RSC Adv       Date:  2018-02-07       Impact factor: 4.036

5.  Natriuretic Peptide Receptor-C is Up-Regulated in the Intima of Advanced Carotid Artery Atherosclerosis.

Authors:  Mohamed A Zayed; Scott D Harring; Dana R Abendschein; Chandu Vemuri; Dongsi Lu; Lisa Detering; Yongjian Liu; Pamela K Woodard
Journal:  J Med Surg Pathol       Date:  2016-07-05

6.  Natriuretic Peptide system and cardiovascular disease.

Authors:  Cacciapuoti Federico
Journal:  Heart Views       Date:  2010-03

Review 7.  Cardiovascular Pleiotropic Effects of Natriuretic Peptides.

Authors:  Maurizio Forte; Michele Madonna; Sonia Schiavon; Valentina Valenti; Francesco Versaci; Giuseppe Biondi Zoccai; Giacomo Frati; Sebastiano Sciarretta
Journal:  Int J Mol Sci       Date:  2019-08-08       Impact factor: 5.923

Review 8.  Natriuretic Peptide Clearance Receptor (NPR-C) Pathway as a Novel Therapeutic Target in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF).

Authors:  Emmanuel Eroume A Egom
Journal:  Front Physiol       Date:  2021-05-21       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.